Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abiraterone acetate and prednisone treatment

Circulating RNAs extracted from liquid biopsies represent a promising source of cancer‐ and therapy‐related biomarkers. We screened whole blood from patients with metastatic castration‐resistant prostate cancer (mCRPC) following their first‐line treatment with abiraterone acetate and prednisone (AA‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Boerrigter, Emmy, Benoist, Guillemette E., van Oort, Inge M., Verhaegh, Gerald W., van Hooij, Onno, Groen, Levi, Smit, Frank, Oving, Irma M., de Mol, Pieter, Smilde, Tineke J., Somford, Diederik M., Mehra, Niven, Schalken, Jack A., van Erp, Nielka P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410566/
https://www.ncbi.nlm.nih.gov/pubmed/33650292
http://dx.doi.org/10.1002/1878-0261.12933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410566/
https://www.ncbi.nlm.nih.gov/pubmed/33650292
http://dx.doi.org/10.1002/1878-0261.12933

Ejemplares similares